TB-500 · Horses
TB-500 for horses
Last reviewed 2026-08-28 · 5 sources
The direct answer
Where the story began
TB-500 is a synthetic fragment of thymosin beta-4, a natural protein that helps injured tissue repair by pulling repair cells toward damage and encouraging new blood vessels to form. In a horse, the injury that matters most is the tendon - a bowed tendon can end a racing career - and tendons heal slowly and often re-injure. Trainers used TB-500 for exactly this and reported faster, more durable returns. That real-world use predates the pet-dog trend by years and is the reason horses are woven into the whole peptide story.
Why the sport banned it
The same property that makes it interesting makes it a problem in competition. A substance that speeds tendon healing changes the game in a racing animal, so regulators prohibited thymosin beta-4 and TB-500, and chemists published methods to detect it in horse urine. The ban is not a ruling on whether it works - it is a response to the possibility that it does, in a setting where using it would be cheating. For any horse that races or competes, this is the fact that overrides all the others: using it is a violation, benefit or not.
Evidence versus stable-lore
Held to an honest standard, the equine case is stronger than the dog case on experience and no stronger on proof. There is a described mechanism, a 2026 scoping review gathering the tissue-healing literature, and decades of hands-on use. There is not a controlled trial in horses comparing TB-500 against rest and structured rehabilitation - and a rested tendon heals on its own, which is exactly what such a trial would have to rule out. Long experience is worth more than nothing and less than a trial, and this has never had the trial.
The practical picture
Horses are large, so doses scale up and the supply economics differ from a small dog, but the fundamentals hold: unapproved compound, unregulated supply, no equine trials, and a hard doping line for any competition horse. A real tendon injury is a job for an equine veterinarian and a proper rehabilitation plan - the standard of care, and the only route that keeps a competing horse eligible. The cross-species safety and legality picture is here: are peptides safe for pets?
Questions people ask
Why is TB-500 associated with racehorses?
Because that is where its real-world use started. Trainers used TB-500 on tendon and ligament injuries - the injuries that end racing careers - and reported faster healing with fewer re-injuries, years before the pet-dog trend. That history is the strongest anecdotal case for the peptide, and it is what prompted racing authorities to ban it and develop urine tests for it.
Is TB-500 banned in horse racing?
Yes. Thymosin beta-4 and TB-500 are prohibited substances in regulated racing, and laboratories have published methods to detect it in horse urine. Using it in a competition horse is a doping violation regardless of any healing benefit. This is the decisive fact for anyone whose horse races or competes.
Does TB-500 actually heal a horse's tendon?
The mechanism is real - thymosin beta-4 promotes repair-cell migration and new blood vessel growth - and trainers report benefit. What is missing is a controlled equine trial comparing it against rest and standard rehabilitation, which is the only way to separate real acceleration from the healing a rested tendon does on its own. So it is a plausible mechanism plus long experience, not proven equine medicine.
Keep reading
Sources
The equine use is largely trainer experience rather than published trials; the sources below cover the tissue-repair mechanism, the 2026 scoping review, and the regulatory status. Full compound sourcing is on the TB-500 library card.
- [1]Thymosin Beta-4 and TB-500 in Tissue Healing: A Scoping Review (2026)reviewA 2026 scoping review of the tissue-healing evidence for thymosin beta-4 and TB-500, including its long history in equine tendon injury and the absence of controlled companion-animal trials. Accessed 2026-08-28.
- [2]Thymosin beta4: actin-sequestering protein moonlights to repair injured tissuesstudyThymosin beta-4, the parent molecule of TB-500, promotes cell migration, new blood vessel growth and tissue repair - the mechanism cited for its use on soft-tissue and tendon injuries. Accessed 2026-08-28.
- [3]Muscle injury-induced thymosin beta4 acts as a chemoattractant for myoblastsstudyShows thymosin beta-4 draws muscle precursor cells toward damaged tissue, the basis for the muscle- and tendon-repair claims. Animal model. Accessed 2026-08-28.
- [4]BPC-157: A Prohibited Peptide and an Unapproved Drug (Operation Supplement Safety, U.S. Department of Defense)regulatoryBPC-157 is not an approved drug for humans and is prohibited in sport by WADA. It has no approved veterinary product either. Accessed 2026-08-28.
- [5]CVM GFI #256: Compounding Animal Drugs from Bulk Drug Substances (FDA)regulatoryFDA's guidance describing the narrow conditions under which it will not act against animal drugs compounded from bulk substances - for non-food animals, by or on the order of a licensed veterinarian, when no approved option works. A research peptide bought online and injected without a vet is outside this. Accessed 2026-08-28.
Pepteca is for education and information only. It does not provide medical advice, diagnosis, or treatment, and its calculators perform unit math only. Always verify with a licensed provider before starting, changing, or stopping any protocol. Many peptides are not approved for human use and may be regulated differently where you live.